Publication:
How infection and vaccination are linked to acute and chronic urticaria: a special focus on COVID-19

dc.contributor.coauthorMunoz, Melba
dc.contributor.coauthorElieh-Ali-Komi, Daniel
dc.contributor.coauthorCriado, Paulo Ricardo
dc.contributor.coauthorPeter, Jonny
dc.contributor.coauthorKolkhir, Pavel
dc.contributor.coauthorCan, Pelin
dc.contributor.coauthorGotua, Maia
dc.contributor.coauthorWedi, Bettina
dc.contributor.coauthorRudenko, Michael
dc.contributor.coauthorEnsina, Luis Felipe
dc.contributor.coauthorGrattan, Clive
dc.contributor.coauthorMaurer, Marcus
dc.contributor.departmentSchool of Medicine
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2025-01-19T10:32:35Z
dc.date.issued2023
dc.description.abstractSince more than a century ago, there has been awareness of the connection between viral infections and the onset and exacerbation of urticaria. Our knowledge about the role of viral infection and vaccination in acute and chronic urticaria improved as a result of the COVID-19 pandemic but it has also highlighted knowledge gaps. Viral infections, especially respiratory tract infections like COVID-19, can trigger the onset of acute urticaria (AU) and the exacerbation of chronic urticaria (CU). Less frequently, vaccination against viruses including SARS-CoV-2 can also lead to new onset urticaria as well as worsening of CU in minority. Here, with a particular focus on COVID-19, we review what is known about the role of viral infections and vaccinations as triggers and causes of acute and chronic urticaria. We also discuss possible mechanistic pathways and outline the unmet needs in our knowledge. Although the underlying mechanisms are not clearly understood, it is believed that viral signals, medications, and stress can activate skin mast cells (MCs). Further studies are needed to fully understand the relevance of viral infections and vaccinations in acute and chronic urticaria and to better clarify causal pathways.
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue7
dc.description.openaccessGreen Published, gold
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.volume15
dc.identifier.doi10.3390/v15071585
dc.identifier.eissn1999-4915
dc.identifier.quartileQ2
dc.identifier.scopus2-s2.0-85166030540
dc.identifier.urihttps://doi.org/10.3390/v15071585
dc.identifier.urihttps://hdl.handle.net/20.500.14288/26449
dc.identifier.wos1036520700001
dc.keywordsUrticaria
dc.keywordsAngioedema
dc.keywordsViral infections
dc.keywordsCOVID-19
dc.keywordsSARS-CoV-2
dc.keywordsOmalizumab
dc.keywordsVaccine
dc.keywordsVaccination
dc.keywordsAdverse events
dc.keywordsExacerbation
dc.keywordsAnaphylaxis
dc.language.isoeng
dc.publisherMDPI
dc.relation.ispartofViruses-Basel
dc.subjectVirology
dc.titleHow infection and vaccination are linked to acute and chronic urticaria: a special focus on COVID-19
dc.typeReview
dspace.entity.typePublication
local.contributor.kuauthorKocatürk, Emek
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
IR05296.pdf
Size:
1.2 MB
Format:
Adobe Portable Document Format